Jupiter Topco LLC Invests $13.68 Million in Danaher Corporation $DHR

Jupiter Topco LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, Holdings Channel.com reports. The fund bought 19,004 shares of the conglomerate’s stock, valued at approximately $13,679,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. EP Wealth Advisors LLC acquired a new position in shares of Danaher during the 2nd quarter worth about $3,807,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after buying an additional 186,584 shares during the last quarter. Puzo Michael J acquired a new stake in Danaher in the 2nd quarter worth about $8,624,000. Madison Asset Management LLC purchased a new stake in Danaher during the 2nd quarter worth approximately $85,451,000. Finally, Legal & General Group Plc increased its stake in Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after buying an additional 43,169 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. DZ Bank initiated coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. Royal Bank Of Canada boosted their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Stifel Nicolaus decreased their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Evercore reaffirmed an “outperform” rating and set a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Finally, TD Cowen dropped their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Trading Up 0.3%

Shares of Danaher stock opened at $216.41 on Friday. The stock has a market cap of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The stock’s 50 day simple moving average is $199.46 and its 200-day simple moving average is $192.52. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter last year, the firm earned $0.77 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.